EP Patent

EP3558964B1 — 4-amino-2-pyrido-bicyclic pyrimidines and use thereof as topoisomerase ii inhibitors

Assigned to Fondazione Istituto Italiano di Tecnologia · Expires 2022-05-04 · 4y expired

What this patent protects

Patent listed against Talzenna.

Drugs covered by this patent

Patent Metadata

Patent number
EP3558964B1
Jurisdiction
EP
Classification
—
Expires
2022-05-04
Drug substance claim
No
Drug product claim
No
Assignee
Fondazione Istituto Italiano di Tecnologia
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.